Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination

F Aslam, A Haque, V Lee, JA Foody - Patient preference and …, 2009 - Taylor & Francis
combination therapies, may improve adherence by reducing the pill burden. The fixed-dose
combination of amlodipine/atorvastatin … The combination of amlodipine/atorvastatin has a …

… combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin

FD Richard Hobbs - Vascular health and risk management, 2007 - Taylor & Francis
… Because lipoproteins that infiltrate the vessel wall initiate the development of atherosclerotic
… single pill (Caduet) is the first combination therapy treating two risk factors simultaneously, …

Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease

VG Athyros, N Katsiki, A Karagiannis… - Current …, 2014 - ingentaconnect.com
… ) showed that combining perindopril and amlodipine in patients … It has been reported that
combined treatment with statin plus … to 12 months of combined treatment with atorvastatin and …

[HTML][HTML] Combined treatment with amlodipine and atorvastatin calcium reduces circulating levels of intercellular adhesion molecule-1 and tumor necrosis factor-α in …

Z Huang, C Chen, S Li, F Kong, P Shan… - Frontiers in Aging …, 2016 - frontiersin.org
… effect of the combination treatment. Indeed, no … -pill combination of amlodipine and atorvastatin
calcium in the present study. The latter pleiotropic effects of amlodipine plus atorvastatin

Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease

WH Frishman, AL Zuckerman - … Review of Cardiovascular Therapy, 2004 - Taylor & Francis
… will act synergistically in reducing atherosclerotic risk is yet to be determined. The … the
efficacy and safety of combined treatment with atorvastatin and amlodipine in patients with …

Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: a subgroup analysis from the PAPA-CAD …

CA Dézsi - Journal of International Medical Research, 2018 - journals.sagepub.com
Combination therapy with an ACEI, a CCB, and a statin is … attributable to the anti-atherosclerotic
activity shared by all three … If atherosclerotic factors are present in the background of this …

Single‐pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study)

R Blank, J LaSalle, R Reeves, J Maroni… - The journal of …, 2005 - Wiley Online Library
… , eight dosage strengths of amlodipine/atorvastatin single pill (5/10, … amlodipine component
7.1 mg and atorvastatin component 26.2 mg. Fifty‐eight patients (4.8%) discontinued therapy

Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular diseases

E Bahiru, AN De Cates, MRB Farr… - … Systematic Reviews, 2017 - cochranelibrary.com
… a Site investigators could request dosages of amlodipine and atorvastatin 5/20 mg and 10/…
This systematic review demonstrates that the effects of fixed‐dose combination therapy on all‐…

Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

CP Lin, YC Tung, FC Hsiao, CH Yang… - The Journal of …, 2020 - Wiley Online Library
… for the prevention of atherosclerotic CVD, compared with the … of atorvastatin combined with
amlodipine effectively prevents … , combination therapy with amlodipine and atorvastatin, but …

Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia

CP Lin, TJ Hsu, YC Tung, FC Hsiao… - Journal of the …, 2024 - Am Heart Assoc
… However, compared with the 5/20 free group, such benefit of the 5/20 fixed regimen dose
was not presented in patients with clinical atherosclerotic CVD, and we assumed that the 5% …